Nortis Inc.
- UEI
- W2BAEFZVHWZ5
- CAGE
- 66AX3
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds -… | National Institute of Environmental Health Sciences | $550,906 | |
| Parvivo system | Food and Drug Administration | $79,500 | |
| RAT and canine microphysiological systems of the kidney proximal tubule for chemical toxicity screening | National Institute of Environmental Health Sciences | $3,920,179 | |
| Organ-on-chip based assays for personalized assessment of renal resilience in aging patients | National Institute on Aging | $300,000 | |
| Organ-on-chip approach for assessing tissue-specific sars-COV-2 infection and response to antiviral therapy | National Center for Advancing Translational Sciences | $4,686,431 |
About Nortis Inc.
Nortis Inc. is a for-profit manufacturer registered in SAM.gov to receive federal contract and grant awards. The company provides biotechnology products and services to U.S. government agencies, focused on organ-on-a-chip technology and microphysiological systems.
Through past prime federal contract awards, Nortis Inc. has provided a Parvivo system to the Food and Drug Administration, Department of Health and Human Services, valued at $79,500, with a completion date of September 2021.
Through past prime federal grant awards, Nortis Inc. has provided liver-on-a-chip platforms to model human variability for liver toxicology studies, funded by the National Institute of Environmental Health Sciences at $275,453; rat and canine microphysiological systems of the kidney proximal tubule for chemical toxicity screening, funded by the National Institute of Environmental Health Sciences at $4,487,480; organ-on-chip based assays for personalized assessment of renal resilience in aging patients, funded by the National Institute on Aging at $300,000; and an organ-on-chip approach for assessing tissue-specific SARS-CoV-2 infection and response to antiviral therapy, funded by the National Center for Advancing Translational Sciences at $4,686,431.
Quick answers
What is Nortis Inc.'s UEI?
Nortis Inc.'s Unique Entity ID (UEI) in SAM.gov is W2BAEFZVHWZ5.
What is Nortis Inc.'s CAGE code?
Nortis Inc.'s CAGE code is 66AX3.
What is Nortis Inc.'s primary NAICS code?
Nortis Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Nortis Inc. registered in SAM.gov?
Nortis Inc.'s SAM.gov registration expired on August 2, 2024.
What is Nortis Inc.'s most recent federal award?
Nortis Inc.'s most recent federal grant award is A liver-on-chip platform to evaluate panels of clinically relevant gene variants for screening of xenobiotic compounds -… (R44ES035556), from National Institute of Environmental Health Sciences, on August 1, 2023.
On GovTribe
See Nortis Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors